CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: June 6, 2012
Result type: Reports
Project Number: SF0281-000
Product Line: Reimbursement Review

Generic Name: Mometasone/formoterol

Brand Name: Zenhale

Manufacturer: Merck Canada Inc.

Therapeutic Area: Asthma

Indications: Asthma maintenance (adults, children 12 or older)

Submission Type: Request For Advice

Project Status: Complete

Date Recommendation Issued: December 19, 2012

Recommendation Type: List with clinical criteria and/or conditions